Insights

Strategic Acquisition Recent acquisition of Visiopharm GmbH by Grundium Oy signals potential expansion and integration opportunities across EMEA. Sales teams should target newly combined customer footprints and leverage cross-sell of AI-driven pathology software across broader lab networks.

EU IVDR Footprint With at least nine diagnostic algorithms cleared under IVDR for EU customers, there is a strong standing in EU markets for diagnostic decision support. Focus sales efforts on EU laboratories seeking compliant AI tools that integrate into existing workflows.

Remote & Integrated Launch of Remote File Cache and ongoing integrations indicate emphasis on seamless data access and interoperability. Target research and clinical centers that value distributed workflows, data sharing, and compatibility with partner platforms.

Strategic Partnerships Existing collaborations with Indica Labs, Molecular Instruments, Agilent (past distribution), and others highlight a track record of co-marketing and joint solutions. Use partner-based selling to reach combined customer bases and offer integrated AI-image analysis with established ecosystems.

Global Reach Headquartered in Denmark with offices across Europe and the United States and 750+ customers in 40+ countries. Leverage international presence to pursue multi-region deals, multi-site deployments, and cross-border support for global life sciences customers.

Visiopharm Tech Stack

Visiopharm uses 8 technology products and services including LinkedIn Ads, Hotjar, Power BI, and more. Explore Visiopharm's tech stack below.

Media & News

Visiopharm's Email Address Formats

Visiopharm uses at least 1 format(s):
Visiopharm Email FormatsExamplePercentage
First.Last@visiopharm.comJohn.Doe@visiopharm.com
69%
Last@visiopharm.comDoe@visiopharm.com
16%
FL@visiopharm.comJD@visiopharm.com
9%
First@visiopharm.comJohn@visiopharm.com
6%

Frequently Asked Questions

What is Visiopharm's official website and social media links?

Minus sign iconPlus sign icon
Visiopharm's official website is visiopharm.com and has social profiles on LinkedInCrunchbase.

How much revenue does Visiopharm generate?

Minus sign iconPlus sign icon
As of August 2026, Visiopharm's annual revenue is estimated to be $10M - $25M.

What is Visiopharm's NAICS code?

Minus sign iconPlus sign icon
Visiopharm's NAICS code is 5112 - Software Publishers.

How many employees does Visiopharm have currently?

Minus sign iconPlus sign icon
As of August 2026, Visiopharm has approximately 90 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: M. G. -. Q. D. P.Cfo: K. D. N.Chief Operating Officer: C. K.. Explore Visiopharm's employee directory with LeadIQ.

What industry does Visiopharm belong to?

Minus sign iconPlus sign icon
Visiopharm operates in the Software Development industry.

What technology does Visiopharm use?

Minus sign iconPlus sign icon
Visiopharm's tech stack includes LinkedIn AdsHotjarPower BIShopifyMicrosoft 365SentryNew RelicPiwik.

What is Visiopharm's email format?

Minus sign iconPlus sign icon
Visiopharm's email format typically follows the pattern of First.Last@visiopharm.com. Find more Visiopharm email formats with LeadIQ.

How much funding has Visiopharm raised to date?

Minus sign iconPlus sign icon
As of August 2026, Visiopharm has raised $15M in funding. The last funding round occurred on Sep 01, 2020.

When was Visiopharm founded?

Minus sign iconPlus sign icon
Visiopharm was founded in 2002.
Visiopharm logo

Visiopharm

Software DevelopmentSouth Denmark, Denmark51-200 Employees

Visiopharm is a software development company focusing on AI-driven precision pathology software for both research and clinical diagnostics. In research, its image-analysis tools help scientists, pathologists, and image-analysis experts generate accurate and reproducible data across tissue-based studies. In diagnostics, the company offers clinical applications with several EU IVDR-cleared algorithms that provide diagnostic decision support and can be readily integrated into existing laboratory workflows. Founded in 2002 and privately owned, Visiopharm operates internationally from its headquarters in Denmark’s Medicon Valley, with offices in Sweden, the UK, Germany, the Netherlands, and the United States, plus local representation in France and China.

Section iconCompany Overview

NAICS Code
5112 - Software Publishers
Founded
2002
Employees
51-200

Section iconFunding & Financials

  • $15M

    Visiopharm has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Sep 01, 2020as a series_unknown.

  • $10M - $25M

    Visiopharm's revenue is estimated to be in the range of $10M - $25M

Section iconFunding & Financials

  • $15M

    Visiopharm has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Sep 01, 2020as a series_unknown.

  • $10M - $25M

    Visiopharm's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.